Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children Aged 6 Months to 2 Years With Influenza and Other Acute Respiratory Viral Infections Against Standard Therapy

NCT05269290 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT05269290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05269290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children Aged 6 Months to 2 Years With Influenza and Other Acute Respiratory Viral Infections Against Standard Therapy
Lead sponsor
Valenta Pharm JSC
Phase
Phase 3
Overall status
Completed
Start date
September 23, 2021
Completion date
July 15, 2022
Enrollment
240 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, common cold, influenza, human